Loading...
Titan Medical Inc.
TMD.TO•TSX
Healthcare
Medical - Devices
CA$1.13
CA$1.07(2150.00%)

Financial performance has remained strong, with revenue growing from $450000.00 in Q3 2023 to $0.00 in Q2 2024. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$1.10M in Q2 2024, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$1.02M. Net income dropped to -$1.06M, keeping EPS at -$0.009. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan